S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
Sell every Stock except ONE (Ad)
As Elizabeth Holmes heads to prison for fraud, many puzzle over her motives
New bill to build Athletics stadium on Las Vegas Strip caps Nevada's cost at $380 million
Sell every Stock except ONE (Ad)
Mechanical sails? Batteries? Shippers forming 'green corridors' to fast-track cleaner technologies
Baby eels remain one of America's most valuable fish after strong year in Maine
Sell every Stock except ONE (Ad)
Teen workers are in high demand for summer and commanding better pay
Biden, GOP reach tentative deal to raise debt ceiling, avoid calamitous US default
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
Sell every Stock except ONE (Ad)
As Elizabeth Holmes heads to prison for fraud, many puzzle over her motives
New bill to build Athletics stadium on Las Vegas Strip caps Nevada's cost at $380 million
Sell every Stock except ONE (Ad)
Mechanical sails? Batteries? Shippers forming 'green corridors' to fast-track cleaner technologies
Baby eels remain one of America's most valuable fish after strong year in Maine
Sell every Stock except ONE (Ad)
Teen workers are in high demand for summer and commanding better pay
Biden, GOP reach tentative deal to raise debt ceiling, avoid calamitous US default
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
Sell every Stock except ONE (Ad)
As Elizabeth Holmes heads to prison for fraud, many puzzle over her motives
New bill to build Athletics stadium on Las Vegas Strip caps Nevada's cost at $380 million
Sell every Stock except ONE (Ad)
Mechanical sails? Batteries? Shippers forming 'green corridors' to fast-track cleaner technologies
Baby eels remain one of America's most valuable fish after strong year in Maine
Sell every Stock except ONE (Ad)
Teen workers are in high demand for summer and commanding better pay
Biden, GOP reach tentative deal to raise debt ceiling, avoid calamitous US default
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
Sell every Stock except ONE (Ad)
As Elizabeth Holmes heads to prison for fraud, many puzzle over her motives
New bill to build Athletics stadium on Las Vegas Strip caps Nevada's cost at $380 million
Sell every Stock except ONE (Ad)
Mechanical sails? Batteries? Shippers forming 'green corridors' to fast-track cleaner technologies
Baby eels remain one of America's most valuable fish after strong year in Maine
Sell every Stock except ONE (Ad)
Teen workers are in high demand for summer and commanding better pay
Biden, GOP reach tentative deal to raise debt ceiling, avoid calamitous US default
NASDAQ:SYBX

Synlogic (SYBX) News Today

$0.56
+0.02 (+3.70%)
(As of 05/26/2023 ET)
Compare
Today's Range
$0.54
$0.57
50-Day Range
$0.49
$0.68
52-Week Range
$0.45
$1.35
Volume
67,261 shs
Average Volume
723,192 shs
Market Capitalization
$38.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.75
Get Synlogic News Delivered to You Automatically

Sign up to receive the latest news and ratings for SYBX and its competitors with MarketBeat's FREE daily newsletter.



SYBX Media Mentions By Week

SYBX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SYBX
News Sentiment

0.40

0.72

Average
Medical
News Sentiment

SYBX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SYBX Articles
This Week

4

2

SYBX Articles
Average Week

SourceHeadline
finance.yahoo.com logoSynlogic Announces Data Presentations at the 2023 Synthetic Biology: Engineering, Evolution & Design (SEED) Conference
finance.yahoo.com - May 24 at 7:03 AM
finance.yahoo.com logoSynlogic to Present at the Jefferies Global Healthcare Conference
finance.yahoo.com - May 23 at 10:56 AM
MarketBeat logoQ3 2023 Earnings Estimate for Synlogic, Inc. (NASDAQ:SYBX) Issued By HC Wainwright
americanbankingnews.com - May 19 at 2:36 AM
msn.com logoHC Wainwright & Co. Reiterates Synlogic (SYBX) Buy Recommendation
msn.com - May 16 at 3:52 AM
markets.businessinsider.com logoH.C. Wainwright Sticks to Its Buy Rating for Synlogic (SYBX)
markets.businessinsider.com - May 15 at 7:51 AM
finance.yahoo.com logoSynlogic First Quarter 2023 Earnings: Beats Expectations
finance.yahoo.com - May 13 at 9:20 AM
markets.businessinsider.com logoChardan Capital Sticks to Its Buy Rating for Synlogic (SYBX)
markets.businessinsider.com - May 12 at 12:45 AM
msn.com logoSynlogic: Q1 Earnings Insights
msn.com - May 11 at 7:45 PM
finanznachrichten.de logoSynlogic, Inc.: Synlogic Reports First Quarter 2023 Financial Results and Provides Business Update
finanznachrichten.de - May 11 at 9:42 AM
finance.yahoo.com logoSynlogic Reports First Quarter 2023 Financial Results and Provides Business Update
finance.yahoo.com - May 11 at 9:42 AM
finance.yahoo.com logoSynlogic, Inc. (SYBX) Reports Q1 Loss, Lags Revenue Estimates
finance.yahoo.com - May 11 at 9:42 AM
msn.com logoSynlogic Soars on Orphan Drug Status Win for SYNB1934
msn.com - May 10 at 6:41 PM
finance.yahoo.com logoAnalysts Estimate Synlogic, Inc. (SYBX) to Report a Decline in Earnings: What to Look Out for
finance.yahoo.com - May 4 at 12:19 PM
MarketBeat logoSynlogic, Inc. (NASDAQ:SYBX) Forecasted to Post Q1 2023 Earnings of ($0.27) Per Share
americanbankingnews.com - May 2 at 1:28 AM
MarketBeat logoShort Interest in Synlogic, Inc. (NASDAQ:SYBX) Increases By 19.0%
americanbankingnews.com - April 30 at 7:28 AM
MarketBeat logoSynlogic, Inc. (NASDAQ:SYBX) to Post FY2024 Earnings of ($1.09) Per Share, HC Wainwright Forecasts
americanbankingnews.com - April 29 at 5:10 AM
MarketBeat logoSynlogic (NASDAQ:SYBX) Earns Buy Rating from HC Wainwright
americanbankingnews.com - April 28 at 7:38 AM
MarketBeat logoSynlogic's (SYBX) Buy Rating Reaffirmed at HC Wainwright
americanbankingnews.com - April 28 at 7:04 AM
MarketBeat logoSynlogic, Inc. (NASDAQ:SYBX) Insider Aoife Brennan Sells 19,042 Shares
americanbankingnews.com - April 7 at 6:54 AM
MarketBeat logoSynlogic, Inc. to Post Q1 2023 Earnings of ($0.23) Per Share, Oppenheimer Forecasts (NASDAQ:SYBX)
americanbankingnews.com - April 5 at 1:20 AM
MarketBeat logoSynlogic, Inc. Expected to Post Q1 2023 Earnings of ($0.24) Per Share (NASDAQ:SYBX)
americanbankingnews.com - April 4 at 1:18 AM
MarketBeat logoChardan Capital Cuts Synlogic (NASDAQ:SYBX) Price Target to $5.50
americanbankingnews.com - April 1 at 5:00 AM
MarketBeat logoSynlogic, Inc. (NASDAQ:SYBX) Forecasted to Post Q1 2024 Earnings of ($0.16) Per Share
americanbankingnews.com - March 31 at 7:58 AM
MarketBeat logoSynlogic, Inc. (NASDAQ:SYBX) Sees Significant Drop in Short Interest
americanbankingnews.com - March 29 at 7:28 AM
finance.yahoo.com logoSynlogic Receives Positive Opinion on Orphan Designation from the European Medicines Agency for SYNB1934 for the Treatment of Phenylketonuria
finance.yahoo.com - March 28 at 8:14 AM
finance.yahoo.com logoSynlogic Announces Data Presentations at the Society for Inherited Metabolic Disorders (SIMD) 44th Annual Meeting
finance.yahoo.com - March 20 at 8:25 AM
finance.yahoo.com logoSynlogic to Present at the Oppenheimer 33rd Annual Healthcare Conference
finance.yahoo.com - March 8 at 9:07 AM
finance.yahoo.com logoSynlogic To Present Three Data Presentations at the Society for Inherited Metabolic Disorders (SIMD) 44th Annual Meeting
finance.yahoo.com - March 7 at 9:30 AM
reuters.com logoSYBX.O
reuters.com - March 3 at 11:45 PM
benzinga.com logoSynlogic Stock (NASDAQ:SYBX), Quotes and News Summary
benzinga.com - February 11 at 9:36 AM
finance.yahoo.com logoSynlogic Announces Participation in Upcoming Investor and Industry Conferences
finance.yahoo.com - January 24 at 7:03 AM
finance.yahoo.com logoSynlogic Receives Rare Pediatric Disease Designation from FDA for SYNB1934 for Phenylketonuria (PKU)
finance.yahoo.com - January 19 at 10:16 AM
finance.yahoo.com logoSynlogic, Inc. (SYBX) Upgraded to Buy: Here's Why
finance.yahoo.com - January 16 at 2:12 PM
finance.yahoo.com logoEven after rising 15% this past week, Synlogic (NASDAQ:SYBX) shareholders are still down 90% over the past five years
finance.yahoo.com - January 14 at 12:00 PM
finance.yahoo.com logoSynlogic Provides Corporate Update and Outlook for 2023
finance.yahoo.com - January 5 at 8:26 AM
reuters.com logoSYBX.A - Synlogic Inc | Stock Price & Latest News | Reuters
reuters.com - December 31 at 6:26 PM
finance.yahoo.com logoSynlogic's Experimental Drug Lowers Urinary Oxalate In Gastric Bypass Patients
finance.yahoo.com - December 23 at 9:58 AM
finance.yahoo.com logoSynlogic Announces Achievement of Proof of Concept for SYNB8802 in Enteric Hyperoxaluria Based on Urinary Oxalate Lowering in Phase 1b Study
finance.yahoo.com - December 15 at 9:21 AM
markets.businessinsider.com logoSVB Securities Reaffirms Their Buy Rating on Synlogic (SYBX)
markets.businessinsider.com - November 14 at 5:25 AM
finance.yahoo.com logoSynlogic Touts Positive Data From Rare Inherited Disorder Trial, Pivotal Study To Start Next Year
finance.yahoo.com - October 26 at 2:33 AM
seekingalpha.com logoSynlogic Stock: SYNB1934 Advances To Phase 3 (NASDAQ:SYBX) - Seeking Alpha
seekingalpha.com - October 20 at 8:38 AM
seekingalpha.com logoSYBX stock gains after early Phase 2 data for phenylketonuria candidates (NASDAQ:SYBX) - Seeking Alpha
seekingalpha.com - October 18 at 11:29 PM
benzinga.com logoSynlogic shares are trading higher after the company announced top-line Phase 2 data for phenylketonuria, saying "both strains demonstrated clinically meaningful reductions in fasting plasma Phe." - Synlogic (NASDAQ:SYBX) - Benzinga
benzinga.com - October 18 at 11:29 PM
marketscreener.com logoOppenheimer Raises Synlogic's Price Target to $8 From $6, Maintains Outperform Rating - Marketscreener.com
marketscreener.com - October 18 at 6:29 PM
globenewswire.com logoSynlogic Announces Positive Top-Line Phase 2 Data for Phenylketonuria (PKU); SYNB1934 Advances to Phase 3 - GlobeNewswire
globenewswire.com - October 18 at 6:29 PM
benzinga.com logoSynlogic Announces Top-Line Phase 2 Data For Phenylketonuria; Says 'Both strains demonstrated clinically meaningful reductions in fasting plasma Phe' - Synlogic (NASDAQ:SYBX) - Benzinga
benzinga.com - October 18 at 8:12 AM
finance.yahoo.com logoSynlogic Announces Positive Top-Line Phase 2 Data for Phenylketonuria (PKU); SYNB1934 Advances to Phase 3 - Yahoo Finance
finance.yahoo.com - October 18 at 8:12 AM
finance.yahoo.com logoSynlogic Announces Positive Top-Line Phase 2 Data for Phenylketonuria (PKU); SYNB1934 Advances to Phase 3
finance.yahoo.com - October 18 at 8:12 AM
reuters.com logoSYBX.OQ - Synlogic Inc | Stock Price & Latest News | Reuters
reuters.com - October 11 at 12:19 PM
marketscreener.com logoSoaring Eagle Acquisition : EXPLANATORY NOTE - Form 8-K - Marketscreener.com
marketscreener.com - October 5 at 12:48 AM
Get Synlogic News Delivered to You Automatically

Sign up to receive the latest news and ratings for SYBX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:SYBX) was last updated on 5/27/2023 by MarketBeat.com Staff

My Account -